Delay in pharmacological treatment of autistic children after recognition of the disorder

Eur Neuropsychopharmacol. 2022 Dec:65:54-55. doi: 10.1016/j.euroneuro.2022.10.012. Epub 2022 Nov 10.

Authors

Antonio Clavenna¹, Massimo Cartabia¹, Ida Fortino², Olivia Leoni², Maurizio Bonati³

Affiliations

¹ Laboratory of Pharmacoepidemiology, Department of Public Health, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
² Directorate General for Health, Lombardy Region, Milan, Italy.
³ Laboratory of Mother and Child Health, Department of Public Health, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

PMID: 36371960
DOI: 10.1016/j.euroneuro.2022.10.012

No abstract available

Keywords: Antipsychotic agents; Autism spectrum disorder; Child; Psychotropic drugs.

Publication types

Letter

MeSH terms

Antipsychotic Agents* / therapeutic use
Autism Spectrum Disorder* / drug therapy
Autistic Disorder* / drug therapy
Child
Humans
Recognition, Psychology

Substances

Antipsychotic Agents